HomeCNSP • NASDAQ
add
CNS Pharmaceuticals Inc
Previous close
$2.28
Day range
$2.15 - $2.29
Year range
$2.06 - $34.80
Market cap
1.83M USD
Avg Volume
38.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.99M | 87.06% |
Net income | -5.96M | -87.50% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.99M | -87.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.20M | 11.45% |
Total assets | 8.62M | -0.89% |
Total liabilities | 4.10M | 62.46% |
Total equity | 4.52M | — |
Shares outstanding | 811.45K | — |
Price to book | 0.32 | — |
Return on assets | -146.05% | — |
Return on capital | -202.34% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.96M | -87.50% |
Cash from operations | -3.05M | 44.22% |
Cash from investing | -18.18K | -333.98% |
Cash from financing | 406.87K | -91.80% |
Net change in cash | -2.66M | -420.39% |
Free cash flow | -1.39M | 77.09% |
About
Founded
2017
Headquarters
Website
Employees
5
